UCHL5 and neoplasm: b-AP15 (also known as VLX1500) inhibited the activity of the deubiquitinases, ubiquitin C-terminal hydrolase 5 (UCHL5) and USP14, inducing tumor cells apoptosis and inhibiting tumor progression [173].